Table 1.
Correlation between FGF5 expression and clinical-pathological characteristic in 15 osteosarcoma patients
| FGF5 expression | ||||
|---|---|---|---|---|
| Characteristics | Case number | Low | High | P-value |
| Gender | ||||
| Male | 9 | 4 | 6 | 0.706 |
| Female | 6 | 2 | 3 | |
| Age | ||||
| ≤25 | 12 | 6 | 6 | 0.185 |
| 25 | 3 | 0 | 3 | |
| Tumor location | ||||
| Tibia/femur | 10 | 4 | 6 | 0.706 |
| Elsewhere | 5 | 2 | 3 | |
| Histology types | ||||
| Osteoblast type | 8 | 5 | 3 | |
| Chondroblast type | 4 | 2 | 2 | 0.467 |
| Other type | 3 | 1 | 2 | |
| X-ray types | ||||
| Osteogenesis type | 5 | 3 | 2 | |
| Osteolysis type | 7 | 3 | 4 | 0.35 |
| Mixed type | 3 | 1 | 2 | |
| Differentiated degree | ||||
| High | 9 | 2 | 7 | 0.035 |
| Low | 6 | 5 | 1 | |
| Tumor size | ||||
| 8 cm | 5 | 4 | 1 | 0.047 |
| 8 cm | 10 | 2 | 8 | |
| Lymph node metastasis | ||||
| Yes | 11 | 2 | 9 | 0.011 |
| No | 4 | 4 | 0 | |
| Tumor stage | ||||
| IIA | 26 | 3 | 0 | 0.044 |
| IIB/III | 34 | 3 | 9 | |